OR51E1 and prostate carcinoma: These observations coupled with previous reports that OR51E1 is expressed in SI-NET [14] and that targeting OR51E1 in prostate cancer cell lines induced senescence [19] prompted us to evaluate if SI-NET responded to exposure of an OR51E1 agonist.